Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment; Groundbreaking preclinical research highlights therapeutic potential of targeting the mechanical barrier in treat

Media coverage

• Title	Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment; Groundbreaking preclinical research highlights therapeutic potential of targeting the mechanical barrier in treat
  Media name/outlet	Business Wire
  Country/Territory	United States
  Date	11/3/21
  Persons	Rong Li